An study using GIS to quantify the percent of pregnant women in Mozambique without access to tetanus toxoid (TT) vaccine at varying distances from health facilities estimated that if women cannot travel more than 5 km to a TT immunization site there will be almost 18,000 neonatal tetanus cases each year that could be prevented, costing the country more than US$362 million in treatment costs and lost productivity. Covering 99% of women with TT will currently require people to travel up to 35 km to obtain an immunization.
Full Citation:
Haidari LA, Brown ST, Constenla D et al.. 2016. The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique. Vaccine. 34(35).
Title of Article: The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique
Author(s): Haidari LA, Brown ST, Constenla D et al.
Publication Year: 2016
Publication Name: Vaccine
Publication Volume: 34(35)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123988/pdf/nihms798301.pdf
DOI (Digital Object Identifier): 10.1016/j.vaccine.2016.06.065
Topics: Economics & Return on Investment
Disease Vaccines: Tetanus
Countries: Mozambique
WHO Regions: Africa